04187nam 22004573 450 991058349390332120240506040710.00-08-102373-1(CKB)4340000000196058(PPN)22804829X(FR-PaCSA)88849421(MiAaPQ)EBC5013716(EXLCZ)99434000000019605820210428d2017 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierPsychotropic Drugs, Prevention and Harm ReductionSan Diego :Elsevier,2017.©2018.1 online resource (164 pages)1-78548-272-6 Front Cover -- Psychotropic Drugs, Prevention and Harm Reduction -- Copyright -- Contents -- Foreword -- Preface -- Introduction -- Part 1: Prevention in Care Environments: Approaches and Practices -- 1. Scientific Data and Political Decisions in the Field of Addictive Behaviors -- 1.1. Introduction -- 1.2. A particularly complex field for decision makers -- 1.3. Heterogeneous decision-making during the last two decades -- 1.4. Summary -- 2. Social Sciences and Practice Renewal: From Prevention, to Identification, to Early Intervention -- 2.1. Introduction -- 2.2. Redefining prevention -- 2.3. What organization and what strategy: organizational expertise -- 2.4. Conclusion -- 2.5. Bibliography -- Part 2: (Re)designing Prevention: Multidisciplinary Outlooks -- 3. The Beautiful Life With or Without Drugs: Questions on Emancipation -- 3.1. Introduction -- 3.2. Theoretical framework on dependency and addiction -- 3.3. Transgression and emancipation -- 3.4. Conclusion -- 3.5. Bibliography -- 4. Tobacco and Alcoholic Beverage Consumption of European Adolescents: Substitutes or Complements? The Value of an All-encompassing Policy -- 4.1. Introduction -- 4.2. Previous studies -- 4.3. Analysis framework -- 4.4. Data and descriptive statistics -- 4.5. Price elasticity and cross-price elasticity results -- 4.6. Discussion -- 4.7. Conclusion -- 4.8. Appendix: robustness test -- 4.9. Acknowledgements -- 4.10. Bibliography -- 5. Animated Images, Words Coming Alive, Reflection in Motion -- 5.1. Introduction -- 5.2. Why animated images? -- 5.3. Practical session -- 5.4. What perspectives? -- Part 3: Psychotropic Uses and Health Policies: International Perspectives -- 6. Towards the Addiction of Adolescents Under Public Protection: Paradoxical Contextualization -- 6.1. Introduction -- 6.2. The "moral area" -- 6.3. Bibliography.7. Socio-anthropological Contributions to the Senegalese Harm Reduction Program -- 7.1. Introduction: drugs in Africa -- 7.2. Subject matter of the presentation -- 7.3. Harm reduction origins in Senegal: UDSEN project -- 7.4. Drug user profile in Dakar -- 7.5. Implication and contribution of social sciences -- 7.6. Discussion -- 7.7. Bibliography -- Part 4: Prevention and Harm Reduction at the User Level -- 8. Promoting Harm Reduction Personal Strategies by Means of Drugs Checking: Its Use in CAARUD -- 8.1. Introduction -- 8.2. Drugs checking and harm reduction -- 8.3. Subjectivity and objectivity of the consumption experience -- 8.4. Co-production of knowledge for harm reduction -- 8.5. Bibliography -- 9. Initiation to Injection: A Community Challenge -- 9.1. Introduction -- 9.2. The first shoot: between apartment and squat… an experience between friends -- 9.3. Methodology -- 9.4. Within the injecting community: status among peers -- 9.5. From the initiator's point of view -- 9.6. Conclusion: what perspectives? -- 9.7. Bibliography -- List of Authors -- Index -- Back Cover.Psychotropic drugsPsychotropic drugsfast(OCoLC)fst01081826Psychotropic drugs.Psychotropic drugs.615.7/88615.788Sahed Imaine1739314Chaufton Antony1739315MiAaPQMiAaPQMiAaPQBOOK9910583493903321Psychotropic Drugs, Prevention and Harm Reduction4163291UNINA